Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock-Reference-Cited by-同舟云学术

Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock

Published:2003-04 Issue:8 Volume:65 Page:1373-1382
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Veres Balazs,Gallyas Ferenc,Varbiro Gabor,Berente Zoltan,Osz Erzsebet,Szekeres Gyorgy,Szabo Csaba,Sumegi Balazs

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference37 articles.

1. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly(ADP-ribose) polymerase-1 deficient mice;Oliver;EMBO J,1999

2. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice;Soriano;Shock,2002

3. Does the activation of poly(ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?;Baechtold;Shock,2001

4. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs;Albertini;J. Crit. Care,2000

5. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents;Jagtap;Crit. Care Med.,2002

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency;Medicinal Research Reviews;2024-06-24

2. Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis;Journal of Thrombosis and Thrombolysis;2024-05-24

3. Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells;International Journal of Hematology;2022-12-28

4. Efficacy of Clinically Used PARP Inhibitors in a Murine Model of Acute Lung Injury;Cells;2022-11-26

5. Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma;Communications Medicine;2022-07-02